Patents by Inventor Louis-Georges Guy

Louis-Georges Guy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8088893
    Abstract: This invention provides HIF-3? nucleic acid and protein sequences. Also provided are methods for using HIF-3? nucleic acids, proteins, fragments, antibodies, probes, and cells, to characterize HIF-3?, modulate HIF-3? cellular levels, induce angiogenesis, improve muscular function, and treat coronary and cardiac diseases in mammals.
    Type: Grant
    Filed: March 10, 2009
    Date of Patent: January 3, 2012
    Assignee: Angiogene Inc.
    Inventors: Louis-Georges Guy, Anouk Fortin
  • Patent number: 7608698
    Abstract: This invention provides HIF-3? nucleic acid and sequences. Also provided are methods for using HIF-3? nucleic acids, proteins, fragments, antibodies, probes, and cells, to characterize HIF-3?, modulate HIF-3? cellular levels, induce angiogenesis, improve muscular function, and treat coronary and cardiac diseases in mammals.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: October 27, 2009
    Assignee: Angiogene Inc.
    Inventors: Louis-Georges Guy, Anouk Fortin
  • Publication number: 20090246180
    Abstract: This invention provides HIF-3? nucleic acid and sequences. Also provided are methods for using HIF-3? nucleic acids, proteins, fragments, antibodies, probes, and cells, to characterize HIF-3?, modulate HIF-3? cellular levels, induce angiogenesis, improve muscular function, and treat coronary and cardiac diseases in mammals.
    Type: Application
    Filed: March 10, 2009
    Publication date: October 1, 2009
    Inventors: Louis-Georges Guy, Anouk Fortin
  • Publication number: 20040241797
    Abstract: The present invention describes methods for modulating gene expression, stabilizing VEGF mRNAs, for inducing angiogenesis, for treating various mammalian diseases including coronary and cardiac diseases and for identifying modulators of gene expression by using human proteins called &agr;CP1, &agr;CP2 and HuR. The invention also describes mRNA stabilizing elements and consensus sequences involved in binding of &agr;CP1, &agr;CP2 and HuR proteins to mRNAs.
    Type: Application
    Filed: February 13, 2004
    Publication date: December 2, 2004
    Inventor: Louis-Georges Guy
  • Publication number: 20030026793
    Abstract: This invention provides HIF-3&agr; nucleic acid and sequences. Also provided are methods for using HIF-3&agr; nucleic acids, proteins, fragments, antibodies, probes, and cells, to characterize HIF-3&agr;, modulate HIF-3&agr; cellular levels, induce angiogenesis, improve muscular function, and treat coronary and cardiac diseases in mammals.
    Type: Application
    Filed: May 23, 2002
    Publication date: February 6, 2003
    Inventor: Louis-Georges Guy